These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21073062)

  • 81. Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection.
    Averhoff F; Mahoney F; Coleman P; Schatz G; Hurwitz E; Margolis H
    Am J Prev Med; 1998 Jul; 15(1):1-8. PubMed ID: 9651632
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Immune response to Engerix-B vaccine in employees at the Clinic for Infectious Diseases in Tuzla].
    Stojić V; Petrović J; Ahmetagić S; Jusufović E; Piljić D; Sabović S; Mott-Divković S; Hodzić A
    Med Arh; 2004; 58(1 Suppl 1):49-51. PubMed ID: 15077455
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Study on the comparative immunogenicity of a recombinant DNA hepatitis B vaccine containing pre-S components of the HBV coat protein with non pre-S containing vaccines.
    Yap I; Guan R; Chan SH
    J Gastroenterol Hepatol; 1995; 10(1):51-5. PubMed ID: 7620108
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Immunogenicity of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in subpopulations of healthy adults 18-70 years of age.
    Janssen JM; Jackson S; Heyward WL; Janssen RS
    Vaccine; 2015 Jul; 33(31):3614-8. PubMed ID: 26067185
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Comparison study of the immunogenicity and safety of 5- and 10-microgram dosages of a recombinant hepatitis B vaccine in healthy children.
    Goldfarb J; Medendorp SV; Nagamori K; Buscarino C; Krause D
    Pediatr Infect Dis J; 1996 Sep; 15(9):768-71. PubMed ID: 8878218
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Safety and immunogenicity of a purified hepatitis B virus vaccine prepared by using recombinant DNA technology.
    Zahradnik JM; Couch RB; Gerin JL
    J Infect Dis; 1987 May; 155(5):903-8. PubMed ID: 2951449
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Safety and immunogenicity of a hepatitis B vaccine formulated with a novel adjuvant system.
    Thoelen S; Van Damme P; Mathei C; Leroux-Roels G; Desombere I; Safary A; Vandepapeliere P; Slaoui M; Meheus A
    Vaccine; 1998 Apr; 16(7):708-14. PubMed ID: 9562690
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Hepatitis B vaccine immunogenicity among nurses of a hospital.
    Piratheepkumar V; Kulendran S; Nadarajah S; Murugananthan K
    Ceylon Med J; 2014 Jun; 59(2):59-60. PubMed ID: 24977424
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Assessment of immunogenicity and safety across two manufacturing lots of a 3-antigen hepatitis B vaccine, Sci-B-Vac®, compared with Engerix-B® in healthy Asian adults: A phase 3 randomized clinical trial.
    Diaz-Mitoma F; Popovic V; Spaans JN
    Vaccine; 2021 Jun; 39(29):3892-3899. PubMed ID: 34116873
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Comparative immunogenicity under field conditions of two recombinant hepatitis B vaccines in 8-10-year-old children.
    Duval B; Boulianne N; De Serres G; Laflamme N; De Wals P; Massé R; Trudeau G; Delage G; Desjardins L
    Vaccine; 2000 Feb; 18(15):1467-72. PubMed ID: 10618544
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Two-Dose Hepatitis B Vaccine (Heplisav-B) Results in Better Seroconversion Than Three-Dose Vaccine (Engerix-B) in Chronic Liver Disease.
    Amjad W; Alukal J; Zhang T; Maheshwari A; Thuluvath PJ
    Dig Dis Sci; 2021 Jun; 66(6):2101-2106. PubMed ID: 32617767
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A comparative trial of standard or high-dose S subunit recombinant hepatitis B vaccine versus a vaccine containing S subunit, pre-S1, and pre-S2 particles for revaccination of healthy adult nonresponders.
    Bertino JS; Tirrell P; Greenberg RN; Keyserling HL; Poland GA; Gump D; Kumar ML; Ramsey K
    J Infect Dis; 1997 Mar; 175(3):678-81. PubMed ID: 9041342
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 1. Safety and immunogenicity in young, healthy adults.
    Leroux-Roels G; Desombere I; De Tollenaere G; Petit MA; Desmons P; Hauser P; Delem A; De Grave D; Safary A
    Vaccine; 1997 Nov; 15(16):1724-31. PubMed ID: 9364674
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Delayed acquisition of neonatal reflexes in newborn primates receiving a thimerosal-containing hepatitis B vaccine: influence of gestational age and birth weight.
    Hewitson L; Houser LA; Stott C; Sackett G; Tomko JL; Atwood D; Blue L; White ER
    J Toxicol Environ Health A; 2010; 73(19):1298-313. PubMed ID: 20711932
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Evaluation of hepatitis B vaccine immunogenicity among older adults during an outbreak response in assisted living facilities.
    Tohme RA; Awosika-Olumo D; Nielsen C; Khuwaja S; Scott J; Xing J; Drobeniuc J; Hu DJ; Turner C; Wafeeg T; Sharapov U; Spradling PR
    Vaccine; 2011 Nov; 29(50):9316-20. PubMed ID: 22015390
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Revaccination of healthy nonresponders with hepatitis B vaccine and prediction of seroprotection response.
    Kim MJ; Nafziger AN; Harro CD; Keyserling HL; Ramsey KM; Drusano GL; Bertino JS
    Vaccine; 2003 Mar; 21(11-12):1174-9. PubMed ID: 12559795
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Adult immunization against hepatitis B: Does the number of jabs matter?
    Oster G; Bornheimer R; Ottino K; Stevenson C; Lewin C; Janssen R
    Vaccine; 2022 Jun; 40(26):3597-3604. PubMed ID: 35570079
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Safety and immunogenicity of indigenous recombinant hepatitis B vaccine (Shanvac-B) in comparison with commercially available vaccine.
    Joshi N; Kumar A; Sreenivas DV; Palan S; Nagarjuna Kumar YR
    Indian J Gastroenterol; 2000; 19(2):71-3. PubMed ID: 10812819
    [TBL] [Abstract][Full Text] [Related]  

  • 99. A Cross-Sectional Study of the Association between Infant Hepatitis B Vaccine Exposure in Boys and the Risk of Adverse Effects as Measured by Receipt of Special Education Services.
    Geier DA; Kern JK; Homme KG; Geier MR
    Int J Environ Res Public Health; 2018 Jan; 15(1):. PubMed ID: 29329213
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Modulation of immune response to rDNA hepatitis B vaccination by psychological stress.
    Jabaaij L; van Hattum J; Vingerhoets JJ; Oostveen FG; Duivenvoorden HJ; Ballieux RE
    J Psychosom Res; 1996 Aug; 41(2):129-37. PubMed ID: 8887826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.